South Korea
· Delayed Price · Currency is KRW Jeil Pharma Holdings Statistics
Total Valuation
KRX:002620 has a market cap or net worth of KRW 131.41 billion. The enterprise value is 355.86 billion.
| Market Cap | 131.41B |
| Enterprise Value | 355.86B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:002620 has 15.35 million shares outstanding. The number of shares has increased by 1.79% in one year.
| Current Share Class | 15.35M |
| Shares Outstanding | 15.35M |
| Shares Change (YoY) | +1.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 76.13% |
| Owned by Institutions (%) | 0.03% |
| Float | 2.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.82, with an EV/FCF ratio of -30.30.
| EV / Earnings | -7.28 |
| EV / Sales | 0.46 |
| EV / EBITDA | 36.82 |
| EV / EBIT | n/a |
| EV / FCF | -30.30 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.12 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 16.64 |
| Debt / FCF | -13.69 |
| Interest Coverage | -0.54 |
Financial Efficiency
Return on equity (ROE) is -13.99% and return on invested capital (ROIC) is -0.46%.
| Return on Equity (ROE) | -13.99% |
| Return on Assets (ROA) | -0.31% |
| Return on Invested Capital (ROIC) | -0.46% |
| Return on Capital Employed (ROCE) | -0.84% |
| Revenue Per Employee | 20.89B |
| Profits Per Employee | -1.32B |
| Employee Count | 37 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 4.46 |
Taxes
In the past 12 months, KRX:002620 has paid 4.93 billion in taxes.
| Income Tax | 4.93B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.65% in the last 52 weeks. The beta is 0.86, so KRX:002620's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -12.65% |
| 50-Day Moving Average | 8,192.40 |
| 200-Day Moving Average | 8,125.30 |
| Relative Strength Index (RSI) | 53.23 |
| Average Volume (20 Days) | 30,553 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:002620 had revenue of KRW 773.03 billion and -48.91 billion in losses. Loss per share was -3,158.31.
| Revenue | 773.03B |
| Gross Profit | 216.13B |
| Operating Income | -4.34B |
| Pretax Income | -55.09B |
| Net Income | -48.91B |
| EBITDA | 9.67B |
| EBIT | -4.34B |
| Loss Per Share | -3,158.31 |
Balance Sheet
The company has 70.55 billion in cash and 160.80 billion in debt, giving a net cash position of -90.25 billion or -5,878.80 per share.
| Cash & Cash Equivalents | 70.55B |
| Total Debt | 160.80B |
| Net Cash | -90.25B |
| Net Cash Per Share | -5,878.80 |
| Equity (Book Value) | 443.62B |
| Book Value Per Share | 20,155.64 |
| Working Capital | 42.13B |
Cash Flow
In the last 12 months, operating cash flow was -7.80 billion and capital expenditures -3.94 billion, giving a free cash flow of -11.74 billion.
| Operating Cash Flow | -7.80B |
| Capital Expenditures | -3.94B |
| Free Cash Flow | -11.74B |
| FCF Per Share | -764.99 |
Margins
Gross margin is 27.96%, with operating and profit margins of -0.56% and -6.33%.
| Gross Margin | 27.96% |
| Operating Margin | -0.56% |
| Pretax Margin | -7.13% |
| Profit Margin | -6.33% |
| EBITDA Margin | 1.25% |
| EBIT Margin | -0.56% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.79% |
| Shareholder Yield | -1.20% |
| Earnings Yield | -37.22% |
| FCF Yield | -8.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 17, 2006. It was a forward split with a ratio of 10.
| Last Split Date | Apr 17, 2006 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
KRX:002620 has an Altman Z-Score of 1.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 3 |